ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 92 filers reported holding ALLOVIR INC in Q3 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,554 | -74.7% | 30,025 | -60.0% | 0.06% | -75.2% |
| Q2 2023 | $255,085 | -13.7% | 75,025 | 0.0% | 0.22% | -38.0% |
| Q1 2023 | $295,599 | -23.2% | 75,025 | 0.0% | 0.36% | -19.0% |
| Q4 2022 | $384,878 | -35.0% | 75,025 | +0.0% | 0.44% | -39.1% |
| Q3 2022 | $592,000 | +102.7% | 75,010 | +0.0% | 0.73% | +131.2% |
| Q2 2022 | $292,000 | – | 75,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |